Once your blood glucose is above 4.0 mmol/L, eat a longer-acting carbohydrate snack if your next meal is not due Do not drive or operate machinery until you have fully recovered from a hypoglycaemic episode Review medication timing and dosing with your healthcare team, particularly if you take insulin or sulphonylureas alongside your GLP-1 agonist Keep a detailed symptom diary to identify patterns or triggers Medication adjustments: Your doctor may consider: Reducing doses of insulin or sulphonylureas if hypoglycaemia is identified as the cause Reviewing the GLP-1 agonist dose titration schedule to ensure gradual increases that minimise side effects Temporarily suspending the GLP-1 agonist to determine whether tremors resolve, though this should only be done under medical supervision after thorough evaluation Lifestyle modifications: Maintain regular meal patterns to stabilise blood glucose levels Ensure adequate hydration and nutrition , particularly if experiencing gastrointestinal side effects Reduce caffeine intake , as excessive consumption can exacerbate tremor Manage stress through relaxation techniques, as anxiety can worsen physiological tremor Avoid alcohol or consume only in moderation, as it can affect blood glucose control and tremor Further investigations: Depending on clinical assessment, your doctor may arrange: Thyroid function tests (TSH, free T4) Vitamin B12 and folate levels Liver and kidney function tests Referral to neurology if an underlying neurological condition is suspected Most importantly, maintain open communication with your diabetes care team

Yes, you can change your semaglutide injection day if you need to, like if your daily schedule is changing and you wont have consistent access to a refrigerator on your injection day
Colombijn JMT, de Leijer JF, Visseren FLJ et al (2025) Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies
Cephalalgia 35(14):12781286 Bathel A, Schweizer L, Stude P et al (2018) Increased thalamic glutamate/glutamine levels in migraineurs